Rahima Zennadi

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Antioxidants (Basel, Switzerland)

International journal of molecular sciences

Blood

Duke University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Duke University

United States

PHD :: Medicine

Publications

Waseem Chauhan, Sudharshan Sj, Sweta Kafle, Rahima Zennadi
SnoRNAs: Exploring Their Implication in Human Diseases. International journal of molecular sciences 25 (13) (2024)
Waseem Chauhan, Sudharshan Sj, Sweta Kafle, Rahima Zennadi
SnoRNAs: Exploring Their Implication in Human Diseases. International journal of molecular sciences 25 (13) (2024)
Waseem Chauhan, Rahima Zennadi
Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Waseem Chauhan, Rahima Zennadi
Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Waseem Chauhan, Rahima Zennadi
Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Naja Nyffenegger, Rahima Zennadi, Natarajaswamy Kalleda, Anna Flace, Giada Ingoglia, Raphael M Buzzi, Cédric Doucerain, Paul W Buehler, Dominik J Schaer, Franz Dürrenberger, Vania Manolova
The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease. Blood 140 (7) (2022)
Qinhong Wang, Rahima Zennadi
The Role of RBC Oxidative Stress in Sickle Cell Disease: From the Molecular Basis to Pathologic Implications. Antioxidants (Basel, Switzerland) 10 (10) (2021)
Qinhong Wang, Rahima Zennadi
Oxidative Stress and Thrombosis during Aging: The Roles of Oxidative Stress in RBCs in Venous Thrombosis. International journal of molecular sciences 21 (12) (2020)

Rahima Zennadi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rahima Zennadi